Observational Study on Efficacy on Glycaemic Control of Slow-Acting Insulin Analogue in Type 2 Diabetes

Trial Profile

Observational Study on Efficacy on Glycaemic Control of Slow-Acting Insulin Analogue in Type 2 Diabetes

Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Feb 2017

At a glance

  • Drugs Insulin detemir (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms LIGHT
  • Sponsors Novo Nordisk
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 14 Oct 2009 Actual end date changed from Aug 2008 to Nov 2008 as reported by ClinicalTrials.gov.
    • 16 Sep 2008 Actual end date (Aug 2008) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top